Kerr McInroy

Ask VT AI
View News Summary
  • Auburn rallies from 11-point halftime deficit to defeat Arkansas 33-24, snapping a four-game skid and earning its first SEC win.
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Shutdown becomes second-longest as stalemate persists between Trump and Democrats over border wall funding.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Auburn rallies from 11-point halftime deficit to defeat Arkansas 33-24, snapping a four-game skid and earning its first SEC win.
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Shutdown becomes second-longest as stalemate persists between Trump and Democrats over border wall funding.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Kerr McInroy